{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T04:32:15Z","timestamp":1793248335782,"version":"4.5.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Shandong Province Natural Science Foundation","doi-asserted-by":"publisher","award":["ZR2022MH162"],"award-info":[{"award-number":["ZR2022MH162"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Shandong Province Natural Science Foundation","doi-asserted-by":"publisher","award":["ZR2022QE202"],"award-info":[{"award-number":["ZR2022QE202"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22309103"],"award-info":[{"award-number":["22309103"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Colloids and Surfaces B: Biointerfaces"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.colsurfb.2025.114557","type":"journal-article","created":{"date-parts":[[2025,2,9]],"date-time":"2025-02-09T01:48:18Z","timestamp":1739065698000},"page":"114557","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["A computer-aided, carrier-free drug delivery system with enhanced cytotoxicity and biocompatibility: A universal model for multifunctional lung cancer therapy"],"prefix":"10.1016","volume":"250","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3185-0257","authenticated-orcid":false,"given":"Zhonglei","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shizeng","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxin","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziling","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.colsurfb.2025.114557_bib1","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA-Cancer J. Clin."},{"issue":"4","key":"10.1016\/j.colsurfb.2025.114557_bib2","article-title":"Pulmonary delivery of mucus-traversing PF127-modified silk fibroin nanoparticles loading with quercetin for lung cancer therapy","volume":"18","author":"Tang","year":"2023","journal-title":"Asian J. Pharm. Sci."},{"key":"10.1016\/j.colsurfb.2025.114557_bib3","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/d41573-023-00017-9","article-title":"The non-small-cell lung cancer drug market","volume":"22","author":"Nawaz","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.colsurfb.2025.114557_bib4","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41572-024-00551-9","article-title":"Non-small-cell lung cancer","volume":"10","author":"Hendriks","year":"2024","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"3","key":"10.1016\/j.colsurfb.2025.114557_bib5","doi-asserted-by":"crossref","first-page":"18","DOI":"10.53388\/TMR20240618001","article-title":"Rising above: exploring the therapeutic potential of natural product-based compounds in human cancer treatment","volume":"10","author":"Yang","year":"2025","journal-title":"Tradit. Med. Res."},{"issue":"3","key":"10.1016\/j.colsurfb.2025.114557_bib6","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202308977","article-title":"Nanomedicine combats drug resistance in lung cancer","volume":"36","author":"Zheng","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.colsurfb.2025.114557_bib7","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/s41571-022-00685-3","article-title":"Mitigating acute chemotherapy-associated adverse events in patients with cancer","volume":"19","author":"Kuderer","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.colsurfb.2025.114557_bib8","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.jcis.2024.08.100","article-title":"A computer-aided, heterodimer-based \u201ctriadic\u201d carrier-free drug delivery platform to mitigate multidrug resistance in lung cancer and enhance efficiency","volume":"677","author":"Yang","year":"2025","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.colsurfb.2025.114557_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2022.100904","article-title":"Nanotechnology-based approaches overcome lung cancer drug resistance through diagnosis and treatment","volume":"66","author":"Li","year":"2023","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.colsurfb.2025.114557_bib10","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1016\/j.addr.2013.08.004","article-title":"Nanopreparations to overcome multidrug resistance in cancer","volume":"65","author":"Patel","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.colsurfb.2025.114557_bib11","article-title":"Linear-like polypeptide-based micelle with pH-sensitive detachable PEG to deliver dimeric camptothecin for cancer therapy","volume":"18","author":"Wong","year":"2023","journal-title":"Asian J. Pharm. Sci."},{"issue":"18","key":"10.1016\/j.colsurfb.2025.114557_bib12","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202206624","article-title":"Metal nanoparticles as novel agents for lung cancer diagnosis and therapy","volume":"19","author":"Zheng","year":"2023","journal-title":"Small"},{"issue":"37","key":"10.1016\/j.colsurfb.2025.114557_bib13","doi-asserted-by":"crossref","first-page":"25372","DOI":"10.1021\/acsnano.4c02940","article-title":"Mitochondrial extracellular vesicles: a promising avenue for diagnosing and treating lung diseases","volume":"18","author":"Ding","year":"2024","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.colsurfb.2025.114557_bib14","doi-asserted-by":"crossref","DOI":"10.1002\/INMD.20220005","article-title":"Dynamic responsiveness of self-assembling peptide-based nano-drug systems","volume":"1","author":"Wang","year":"2023","journal-title":"Interdiscip. Med."},{"issue":"2","key":"10.1016\/j.colsurfb.2025.114557_bib15","article-title":"Self-assembled organic\/metal ion nanohybrids for theranostics","volume":"1","author":"Zhang","year":"2020","journal-title":"VIEW"},{"issue":"6","key":"10.1016\/j.colsurfb.2025.114557_bib16","article-title":"Programmed initiation and enhancement of cGAS\/STING pathway for tumour immunotherapy via tailor-designed ZnFe2O4-based nanosystem","volume":"3","author":"Yang","year":"2023","journal-title":"Exploration"},{"key":"10.1016\/j.colsurfb.2025.114557_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.snb.2022.131417","article-title":"Desolvation-induced formation of recombinant camel serum albumin-based nanocomposite for glutathione colorimetric determination","volume":"357","author":"Zhang","year":"2022","journal-title":"Sens. Actuators B Chem."},{"key":"10.1016\/j.colsurfb.2025.114557_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2023.146421","article-title":"Lysozyme-based nanozyme encapsulated in double-network hydrogel for monitoring and repair of MRSA infected wounds","volume":"477","author":"Le","year":"2023","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.colsurfb.2025.114557_bib19","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1016\/j.ijbiomac.2021.11.042","article-title":"Self-assembled recombinant camel serum albumin nanoparticles-encapsulated hemin with peroxidase-like activity for colorimetric detection of hydrogen peroxide and glucose","volume":"193","author":"Zhang","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.colsurfb.2025.114557_bib20","article-title":"Self-assembly of the chaperonin GroEL nanocage induced at submicellar detergent","volume":"4","author":"Chen","year":"2014","journal-title":"Sci. Rep."},{"key":"10.1016\/j.colsurfb.2025.114557_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115259","article-title":"Recent progress in nanocarrier-based drug delivery systems for antitumour metastasis","volume":"252","author":"Peng","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.colsurfb.2025.114557_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107150","article-title":"Natural-product-based, carrier-free, noncovalent nanoparticles for tumor chemo-photodynamic combination therapy","volume":"203","author":"Wang","year":"2024","journal-title":"Pharmacol. Res."},{"issue":"37","key":"10.1016\/j.colsurfb.2025.114557_bib23","doi-asserted-by":"crossref","first-page":"17673","DOI":"10.1039\/D2NJ03231G","article-title":"An activatable, carrier-free, triple-combination nanomedicine for ALK\/EGFR-mutant non-small cell lung cancer highly permeable targeted chemotherapy","volume":"46","author":"Wang","year":"2022","journal-title":"New J. Chem."},{"issue":"11","key":"10.1016\/j.colsurfb.2025.114557_bib24","doi-asserted-by":"crossref","DOI":"10.1002\/smsc.202400280","article-title":"Transformative impact of nanocarrier-mediated drug delivery: overcoming biological barriers and expanding therapeutic horizons","volume":"4","author":"Kim","year":"2024","journal-title":"Small Sci."},{"issue":"1","key":"10.1016\/j.colsurfb.2025.114557_bib25","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1021\/acs.jmedchem.9b00964","article-title":"Structure defines function: clinically relevant mutations in ErbB kinases","volume":"63","author":"Niggenaber","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.colsurfb.2025.114557_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107123","article-title":"PIK3CA mutation as an acquired resistance driver to EGFR-TKIs in non-small cell lung cancer: clinical challenges and opportunities","volume":"202","author":"Liu","year":"2024","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.colsurfb.2025.114557_bib27","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.canlet.2020.05.009","article-title":"LncRNA H19 downregulation confers erlotinib resistance through upregulation of PKM2 and phosphorylation of AKT in EGFR-mutant lung cancers","volume":"486","author":"Chen","year":"2020","journal-title":"Cancer Lett."},{"issue":"2","key":"10.1016\/j.colsurfb.2025.114557_bib28","doi-asserted-by":"crossref","DOI":"10.1002\/INMD.20230029","article-title":"Nanoparticles derived from herbal preparations may represent a novel nucleic acid therapy","volume":"2","author":"Feng","year":"2024","journal-title":"Interdiscip. Med."},{"issue":"6","key":"10.1016\/j.colsurfb.2025.114557_bib29","doi-asserted-by":"crossref","first-page":"689","DOI":"10.3390\/biomedicines9060689","article-title":"Natural products, alone or in combination with FDA-approved drugs, to treat COVID-19 and lung cancer","volume":"9","author":"Yang","year":"2021","journal-title":"Biomedicines"},{"issue":"4","key":"10.1016\/j.colsurfb.2025.114557_bib30","doi-asserted-by":"crossref","DOI":"10.1002\/INMD.20240027","article-title":"Mini-review of developments in the chemical modification of plant-derived photosensitizing drug hypocrellin and its biomedical applications","volume":"2","author":"Wu","year":"2024","journal-title":"Interdiscip. Med."},{"issue":"24","key":"10.1016\/j.colsurfb.2025.114557_bib31","doi-asserted-by":"crossref","first-page":"4609","DOI":"10.1111\/bph.14793","article-title":"Ursolic acid promotes apoptosis and mediates transcriptional suppression of CT45A2 gene expression in non-small-cell lung carcinoma harbouring EGFR T790M mutations","volume":"176","author":"Yang","year":"2019","journal-title":"Br. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.colsurfb.2025.114557_bib32","first-page":"1816","article-title":"Autophagy inhibition enhances the inhibitory effects of ursolic acid on lung cancer cells","volume":"46","author":"Wang","year":"2020","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.colsurfb.2025.114557_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27217466","article-title":"Evidence of the beneficial effects of ursolic acid against lung cancer","volume":"27","author":"Kornel","year":"2022","journal-title":"Molecules"},{"issue":"5","key":"10.1016\/j.colsurfb.2025.114557_bib34","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/tox.22891","article-title":"The miRNA-149-5p\/MyD88 axis is responsible for ursolic acid-mediated attenuation of the stemness and chemoresistance of non-small cell lung cancer cells","volume":"35","author":"Chen","year":"2020","journal-title":"Environ. Toxicol."},{"issue":"6","key":"10.1016\/j.colsurfb.2025.114557_bib35","first-page":"685","article-title":"Evolution from small molecule to nano-drug delivery systems-an emerging approach for cancer therapy of ursolic acid","volume":"15","author":"Shao","year":"2020","journal-title":"Asian J. Pharm. Sci."},{"issue":"4","key":"10.1016\/j.colsurfb.2025.114557_bib36","first-page":"509","article-title":"Traditional Chinese medicines for non-small cell lung cancer: therapies and mechanisms","volume":"15","author":"Kong","year":"2023","journal-title":"Chin. Herb. Med."},{"issue":"25","key":"10.1016\/j.colsurfb.2025.114557_bib37","doi-asserted-by":"crossref","first-page":"9812","DOI":"10.1002\/anie.201913249","article-title":"High-performance quinoline-malononitrile core as a building block for the diversity-oriented synthesis of AIEgens","volume":"59","author":"Guo","year":"2020","journal-title":"Angew. Chem. Int. Ed."},{"issue":"25","key":"10.1016\/j.colsurfb.2025.114557_bib38","doi-asserted-by":"crossref","first-page":"10186","DOI":"10.1002\/anie.202001675","article-title":"An activatable AIEgen probe for high-fidelity monitoring of overexpressed tumor enzyme activity and its application to surgical tumor excision","volume":"59","author":"Li","year":"2020","journal-title":"Angew. Chem. Int. Ed."},{"issue":"5","key":"10.1016\/j.colsurfb.2025.114557_bib39","article-title":"Combination therapy to overcome ferroptosis resistance by biomimetic self-assembly nano-prodrug","volume":"18","author":"Huang","year":"2023","journal-title":"Asian J. Pharm. Sci."},{"issue":"35","key":"10.1016\/j.colsurfb.2025.114557_bib40","doi-asserted-by":"crossref","first-page":"29505","DOI":"10.1021\/acsami.7b07565","article-title":"Construction of a supramolecular drug\u2013drug delivery system for non-small-cell lung cancer therapy","volume":"9","author":"Zhang","year":"2017","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.colsurfb.2025.114557_bib41","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jcis.2024.10.075","article-title":"Paclitaxel prodrug nanoparticles boost antitumor efficacy via hitchhiking of human serum albumin","volume":"679","author":"Lu","year":"2025","journal-title":"J. Colloid Interface Sci."},{"issue":"2","key":"10.1016\/j.colsurfb.2025.114557_bib42","article-title":"Fine-tuning the activation behaviors of ternary modular cabazitaxel prodrugs for efficient and on-target oral anti-cancer therapy","volume":"19","author":"Zhang","year":"2024","journal-title":"Asian J. Pharm. Sci."},{"issue":"4","key":"10.1016\/j.colsurfb.2025.114557_bib43","article-title":"A natural compound-empowered podophyllotoxin prodrug nanoassembly magnifies efficacy-toxicity benefits in cancer chemotherapy","volume":"19","author":"Lin","year":"2024","journal-title":"Asian J. Pharm. Sci."},{"key":"10.1016\/j.colsurfb.2025.114557_bib44","article-title":"Multifunctional liposomal complex for detection of the acquired resistance to EGFR-TKIs and synergistic anticancer phototherapy","volume":"38","author":"Yang","year":"2024","journal-title":"Appl. Mater. Today"}],"container-title":["Colloids and Surfaces B: Biointerfaces"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0927776525000645?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0927776525000645?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T08:14:41Z","timestamp":1762330481000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0927776525000645"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":44,"alternative-id":["S0927776525000645"],"URL":"https:\/\/doi.org\/10.1016\/j.colsurfb.2025.114557","relation":{},"ISSN":["0927-7765"],"issn-type":[{"value":"0927-7765","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A computer-aided, carrier-free drug delivery system with enhanced cytotoxicity and biocompatibility: A universal model for multifunctional lung cancer therapy","name":"articletitle","label":"Article Title"},{"value":"Colloids and Surfaces B: Biointerfaces","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.colsurfb.2025.114557","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114557"}}